Education
About Us
Working with TipRanks
Follow Us
Seelos Therapeutics (SEELQ)
OTHER OTC:SEELQ
Seelos Therapeutics (SEELQ) Ownership Overview
1.04% Mutual Funds
1.83% Other Institutional Investors
97.14% Public Companies and
Individual Investors
The ownership structure of Seelos Therapeutics (SEELQ) stock is a mix of institutional, retail, and individual investors. , and 97.14% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 86,869 | Insider | 7.73% | 15,636 | |
| 20,543 | Institution | 1.83% | 3,698 | |
| 11,646 | Institution | 1.04% | 2,096 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,646 | Institution | 1.04% | 2,096 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Seelos Therapeutics (SEELQ)?
Currently, no data Available
What percentage of Seelos Therapeutics (SEELQ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.83% of Seelos Therapeutics (SEELQ) stock is held by institutional investors.
What percentage of Seelos Therapeutics (SEELQ) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.14% of Seelos Therapeutics (SEELQ) stock is held by retail investors.
Who owns the most shares of Seelos Therapeutics (SEELQ)?
Michael Joseph Golembiewski owns the most shares of Seelos Therapeutics (SEELQ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.